Physician profile
Marcus Lawrence Wise
NPI 1407698889
$567.33
in general payments reported to CMS, 2019-2025
7 companies · $522 in 2025
The $522 reported for 2025 was more than what 78% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $45.28 · 2025: $522.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $522 · Entertainment: $45.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $522.05 |
| Entertainment | $45.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $218.04 | 2025 | Miebo, Xiidra, Infuse |
| Alcon Vision LLC | $119.69 | 2025 | Precision7 |
| Sun Pharmaceutical Industries INC. | $76.40 | 2025 | |
| Coopervision INC. | $60.79 | 2025 | Misight Contact Lens |
| Optos, INC. | $45.28 | 2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Carl Zeiss Meditec USA, INC. | $24.13 | 2025 | Visuref 100 |
| Tarsus Pharmaceuticals, INC. | $23.00 | 2025 | Xdemvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcus Wise listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.